Efficacy and safety of rivaroxaban in patients with diabetes and nonvalvular atrial fibrillation: the Rivaroxaban Once-daily, Oral, Direct Factor Xa Inhibition Compared with Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atrial Fibrillation (ROCKET AF Trial).

There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

Abstract

The prevalence of both atrial fibrillation (AF) and diabetes mellitus (DM) are rising, and these conditions often occur together. Also, DM is an independent risk factor for stroke in patients with AF. We aimed to examine the safety and efficacy of rivaroxaban vs warfarin in patients with nonvalvular AF and DM in a prespecified secondary analysis of the ROCKET AF trial.

Related collections

Author and article information

Journal

Journal ID (iso-abbrev): Am. Heart J.

Title: American heart journal

Publisher: Elsevier BV

ISSN (Electronic): 1097-6744

ISSN (Print): 0002-8703

Publication date (Electronic): Oct 2015

Volume: 170

Issue: 4

Affiliations

[1 ] Icahn School of Medicine at Mount Sinai, New York, NY.

[2 ] Icahn School of Medicine at Mount Sinai, New York, NY. Electronic address: jonathan.halperin@mssm.edu.

[3 ] Duke Clinical Research Institute, Duke University Medical Center, Durham, NC.

[4 ] University of Cincinnati College of Medicine, Cincinnati, OH.

[5 ] Department of Cardiovascular Medicine, Division of Electrophysiology, University Hospital Münster, Münster, Germany.

[6 ] Ruprecht-Karls University, Heidelberg, Germany.

[7 ] School of Medicine and Pharmacology, University of Western Australia, Crawley, Australia.

[8 ] Janssen Research & Development, Raritan, NJ.

[9 ] Massachusetts General Hospital and Harvard Medical School, Boston, MA.

[10 ] Bayer HealthCare Pharmaceuticals, Whippany, NJ.

[11 ] Department of Medicine, Stanford University, Stanford, CA.

[12 ] University of Edinburgh and Royal Infirmary of Edinburgh, Edinburgh, United Kingdom.

Article

Publisher Item ID: S0002-8703(15)00443-3

DOI: 10.1016/j.ahj.2015.07.006

PubMed ID: 26386791

SO-VID: e086b32d-e62a-4ed3-98e0-a6258248358d

History

Data availability:

Comments

Comment on this article

scite_

Cited by 37

See all cited by

- Version 1